Browsing: Health

By Marcelo Teixeira NEW YORK, Feb 20 (Reuters) – The U.S. sugar industry could be impacted by regulatory changes as…

Feb 23 (Reuters) – Eli Lilly said on Monday it received the U.S. Food and ‌Drug Administration’s approval to launch…

President Donald Trump blasted Tylenol this week, promoting unproven links between the pain reliever and autism and pushing the well-established…

By Christy Santhosh (Reuters) -Drugmaker Bristol Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital…

By Diana Novak Jones (Reuters) -A U.S. judge on Tuesday rejected Humana’s bid to challenge the Centers for Medicare &…

By Puyaan Singh and Sahil Pandey (Reuters) -Labcorp forecast lower annual revenue growth for its contract research unit on Tuesday,…

By Michael Erman and Puyaan Singh (Reuters) -Bristol Myers Squibb beat Wall Street estimates for third-quarter revenue on Thursday, as…

(Reuters) -AbbVie raised its 2025 profit forecast on Friday, after strong sales of newer immunology drugs Skyrizi and Rinvoq helped…

By Jessica DiNapoli and Abigail Summerville NEW YORK (Reuters) -Kimberly-Clark’s nearly $50 billion offer for Tylenol maker Kenvue is a…

(Reuters) -India’s Mankind Pharma reported a fourth straight quarter of profit fall on Thursday, as the government’s sweeping cuts on…